PROGRAM

TCT 2019 will feature a host of sponsored satellite programs offering attendees comprehensive insights into important interventional topics and issues facing interventional specialists. 

Sponsored sessions include breakfast programs, lunchtime Presentation Theater programs, and evening programming. 

Satellite Programs

SuperSaturated Oxygen in STEMI to Reduce Infarct Size – A New FDA-Approved Therapy

Breakfast Program

09/26/2019 06:45:00 09/26/2019 07:45:00 SuperSaturated Oxygen in STEMI to Reduce Infarct Size – A New FDA-Approved Therapy TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Breakfast Program

Thursday, September 26, 2019
Breakfast: 6:30 am  | 
Program: 6:45 am-7:45 am
The Moscone Center, Room 215, Level 2, Moscone South

SuperSaturated Oxygen in STEMI to Reduce Infarct Size – A New FDA-Approved Therapy

SuperSaturated Oxygen in STEMI to Reduce Infarct Size – A New FDA-Approved Therapy

Sponsored by TherOx, Inc.

Chair  

Gregg W. Stone, MD

Columbia University Medical Center

New York, NY

Faculty  

Suzanne de Waha-Thiele, MD

University Heart Center Lubeck

Lubeck, Germany

 

E. Magnus Ohman, MD

Duke University Medical Center

Durham, NC

 

Richard A. Schatz, MD

Scripps Clinic

La Jolla, CA

 

J. Richard Spears, MD

Beaumont Heart & Vascular Center

Dearborn, MI

Agenda

6:45 am

Introduction

Gregg W. Stone

6:50 am

Importance of Infarct Size and Microvascular Obstruction in STEMI

Suzanne de Waha-Thiele

7:00 am

Failed Therapeutic Approaches (Drugs and Devices) to Reduce Infarct Size

E. Magnus Ohman

7:10 am

SuperSaturated Oxygen Therapy: Background and Mechanism of Action

J. Richard Spears

7:20 am

SSO2 Therapy: Clinical Evidence and Outcomes

Gregg W. Stone

7:30 am

SSO2 Therapy: Case Study

Richard A. Schatz

7:40 am

Discussion

Moderator : Gregg W. Stone

Discussants : Suzanne de Waha-Thiele, E. Magnus Ohman, Richard A. Schatz, J. Richard Spears

7:45 am

Adjourn